Product NDC: | 55154-4575 |
Proprietary Name: | Prandin |
Non Proprietary Name: | repaglinide |
Active Ingredient(s): | 1 mg/1 & nbsp; repaglinide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-4575 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020741 |
Marketing Category: | NDA |
Start Marketing Date: | 20000103 |
Package NDC: | 55154-4575-0 |
Package Description: | 10 POUCH in 1 BAG (55154-4575-0) > 1 TABLET in 1 POUCH |
NDC Code | 55154-4575-0 |
Proprietary Name | Prandin |
Package Description | 10 POUCH in 1 BAG (55154-4575-0) > 1 TABLET in 1 POUCH |
Product NDC | 55154-4575 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | repaglinide |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20000103 |
Marketing Category Name | NDA |
Labeler Name | Cardinal Health |
Substance Name | REPAGLINIDE |
Strength Number | 1 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Glinide [EPC],Potassium Channel Antagonists [MoA] |